Paper37795100
Expanded Hemodialysis ameliorates uremia-induced impairment of vasculoprotective KLF2 and concomitant proinflammatory priming of endothelial cells through an ERK/AP1/cFOS-dependent mechanism.
Zhao H and 14 others. Front Immunol, 2023. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. Expanded Hemodialysis ameliorates uremia-induced impairment of vasculoprotective KLF2 and concomitant proinflammatory priming of endothelial cells through an ERK/AP1/cFOS-dependent mechanism. Papers, record 37795100. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37795100
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Expanded Hemodialysis ameliorates uremia-induced impairment of vasculoprotective KLF2 and concomitant proinflammatory priming of endothelial cells through an ERK/AP1/cFOS-dependent mechanism.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Uremia | Major topic |
| Kidney Failure, Chronic | Major topic |
| Humans | |
| Endothelial Cells | |
| Renal Dialysis | |
| Transcription Factors | |
| Inflammation | |
| Kruppel-Like Transcription Factors | |
| Cephalosporins |
Source PubMed
References76
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23727164 | Kidney failure: aims for the next 10 years and barriers to success. | Lancet | 2013 | https://conductscience.org/library/papers/23727164 | PubMed |
| 2 | 33752206 | Global Epidemiology of End-Stage Kidney Disease and Disparities in Kidney Replacement Therapy. | Am J Nephrol | 2021 | https://conductscience.org/library/papers/33752206 | PubMed |
| 3 | 26192403 | Different Procoagulant Activity of Therapeutic Mesenchymal Stromal Cells Derived from Bone Marrow and Placental Decidua. | Stem Cells Dev | 2015 | https://conductscience.org/library/papers/26192403 | PubMed |
| 4 | 9069263 | AP-1 function and regulation. | Curr Opin Cell Biol | 1997 | https://conductscience.org/library/papers/9069263 | PubMed |
| 5 | 22326498 | Indoxyl sulfate upregulates renal expression of MCP-1 via production of ROS and activation of NF-κB, p53, ERK, and JNK in proximal tubular cells. | Life Sci | 2012 | https://conductscience.org/library/papers/22326498 | PubMed |
| 6 | 25496217 | TLR4 and NALP3 inflammasome in the development of endothelial dysfunction in uraemia. | Eur J Clin Invest | 2015 | https://conductscience.org/library/papers/25496217 | PubMed |
| 7 | 20606606 | Flow cessation triggers endothelial dysfunction during organ cold storage conditions: strategies for pharmacologic intervention. | Transplantation | 2010 | https://conductscience.org/library/papers/20606606 | PubMed |
| 8 | 37398691 | Expanded hemodialysis: what's up, Doc? | Clin Kidney J | 2023 | https://conductscience.org/library/papers/37398691 | PubMed |
| 9 | 17194892 | KLF2 suppresses TGF-beta signaling in endothelium through induction of Smad7 and inhibition of AP-1. | Arterioscler Thromb Vasc Biol | 2007 | https://conductscience.org/library/papers/17194892 | PubMed |
| 10 | 16788687 | Cardiovascular events following renal transplantation: role of traditional and transplant-specific risk factors. | Kidney Int | 2006 | https://conductscience.org/library/papers/16788687 | PubMed |
| 11 | 22182511 | MEK/Erk-based negative feedback mechanism involved in control of Steel Factor-triggered production of Krüppel-like factor 2 in mast cells. | Cell Signal | 2012 | https://conductscience.org/library/papers/22182511 | PubMed |
| 12 | 15511630 | Effects of chronic renal failure on caveolin-1, guanylate cyclase and AKT protein expression. | Biochim Biophys Acta | 2004 | https://conductscience.org/library/papers/15511630 | PubMed |
| 13 | 27445317 | High cut-off dialysis in chronic haemodialysis patients reduces serum procalcific activity. | Nephrol Dial Transplant | 2016 | https://conductscience.org/library/papers/27445317 | PubMed |
| 14 | 35409344 | Molecular Effects of Auto-Antibodies on Angiotensin II Type 1 Receptor Signaling and Cell Proliferation. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35409344 | PubMed |
| 15 | 23337206 | Indoxyl sulfate counteracts endothelial effects of erythropoietin through suppression of Akt phosphorylation. | Circ J | 2013 | https://conductscience.org/library/papers/23337206 | PubMed |
| 16 | 35185912 | Angiogenic Role of Mesothelium-Derived Chemokine CXCL1 During Unfavorable Peritoneal Tissue Remodeling in Patients Receiving Peritoneal Dialysis as Renal Replacement Therapy. | Front Immunol | 2022 | https://conductscience.org/library/papers/35185912 | PubMed |
| 17 | 15894895 | Differential regulation of smooth muscle markers in human bone marrow-derived mesenchymal stem cells. | J Hypertens | 2005 | https://conductscience.org/library/papers/15894895 | PubMed |
| 18 | 28992202 | Krüppel-like factors and vascular wall homeostasis. | J Mol Cell Biol | 2017 | https://conductscience.org/library/papers/28992202 | PubMed |
| 19 | 34253708 | The zinc finger transcription factor, KLF2, protects against COVID-19 associated endothelial dysfunction. | Signal Transduct Target Ther | 2021 | https://conductscience.org/library/papers/34253708 | PubMed |
| 20 | 27852611 | The critical role of Krüppel-like factors in kidney disease. | Am J Physiol Renal Physiol | 2017 | https://conductscience.org/library/papers/27852611 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42793073 | The Heart-Kidney Axis in Heart Failure and Chronic Kidney Disease: Mechanisms, Mediators, and Therapeutic Implications. | Biomolecules | 2026 | https://conductscience.org/library/papers/42793073 | PubMed |
| 42124547 | Preemptive Vascular Access Placement and Mortality Risk in Hemodialysis Patients: A Real-World Single-Center Study. | Hemodial Int | 2026 | https://conductscience.org/library/papers/42124547 | PubMed |
| 40597013 | Prognostic implications of systemic immune-inflammation index and systemic inflammation response index in hemodialysis patients. | BMC Nephrol | 2025 | https://conductscience.org/library/papers/40597013 | PubMed |
| 39647913 | Therapeutic potential of omentin-1 in preeclampsia: enhancing fetal outcomes, vascular function, and reducing inflammation. | Exp Anim | 2025 | https://conductscience.org/library/papers/39647913 | PubMed |
| 39533444 | Inflammatory index is a promising biomarker for maintenance hemodialysis patients with cardiovascular disease. | Eur J Med Res | 2024 | https://conductscience.org/library/papers/39533444 | PubMed |
| 38558808 | Editorial: Emerging talents in alloimmunity and transplantation: 2022. | Front Immunol | 2024 | https://conductscience.org/library/papers/38558808 | PubMed |
| 37965310 | Autoantibodies from patients with kidney allograft vasculopathy stimulate a proinflammatory switch in endothelial cells and monocytes mediated via GPCR-directed PAR1-TNF-α signaling. | Front Immunol | 2023 | https://conductscience.org/library/papers/37965310 | PubMed |
Genes36
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37795100
GET https://conductscience.org/api/papers/v1/37795100/references?page=2